MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmicb.2026.1821617

Медицинская библиотека · Frontiers in microbiology · 2026

Efficacy of drug regimens containing omadacycline in a murine model of Mycobacterium avium chronic lung infection.

Lanoix Jean-Philippe, Froment Antoine, Delomez Julia, Pierce Jessica V, Serio Alisa W, Choquet Morgane, Perret Marie, Peltier François, Joseph Cédric, Chatelain Denis, Andréjak Claire

СтатьяПеревод в очереди

Аннотация

Mycobacterium avium complex (MAC) is the most common non-tuberculous mycobacteria (NTM) and most frequent causative pathogen of NTM pulmonary infections. MAC is often associated with comorbidities, chronic infections, and high mortality rates. New treatment options are needed to increase treatment efficacy and tolerance. Omadacycline is a semisynthetic tetracycline-class drug with broad-spectrum activity, including against MAC in vitro. In an aerosol infection model of MAC pulmonary disease, we evaluated 9 treatment regimens that included omadacycline (OMC) alone or in dual, triple, or quadruple combinations with existing antibiotics: rifampin (RIF), clofazimine (CFZ), ethambutol (EMB), and clarithromycin (CLR). Treatment efficacy was assessed based on reduction of bacterial load in the lung and spleen over 4 months. OMC alone and OMC-RIF-EMB groups demonstrated efficacy starting at 2 months of treatment with a final reduction in bacterial burden in the lung of ~1 log10 and >4 log10, respectively, compared with untreated mice. Omadacycline was as efficacious as rifampin in the standard-of-care regimen (CLR-RIF-EMB) over the first 3 months. The most potent combination tested in this study was OMC-CLR-CFZ, with a >5 log10 reduction of bacterial burden in the lung. This is the first study demonstrating omadacycline efficacy against M. avium in mice alone and as part of a combination regimen. These data suggest that further evaluation of omadacycline for the treatment of MAC-PD is warranted.

Для цитирования: Lanoix Jean-Philippe, Froment Antoine, Delomez Julia, Pierce Jessica V, Serio Alisa W, Choquet Morgane, Perret Marie, Peltier François, Joseph Cédric, Chatelain Denis, Andréjak Claire. Efficacy of drug regimens containing omadacycline in a murine model of Mycobacterium avium chronic lung infection.. Frontiers in microbiology. 2026. DOI: 10.3389/fmicb.2026.1821617.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.